glp 1 compound tirzepatide compound Compounded GLP-1/GIP (Tirzepatide) action GLP Compounded GLP-1 & GIP
Description
Higher insulin drives weight gain, which increases insulin resistance, which raises insulin levels even more, which further disrupts your hormones

96% of patients lose at least 5%, and over 50% lose 20% or more

Recommendation: avoid or severely limit alcohol during the first week after each dose increase

Cigna may cover Ozempic in these cases, but prior authorization is typically still required

FCI/FCQ and BIS evaluations underscore the cravings, disinhibition, and impulsivity-curbing ability of Tirzepatide, further demonstrating that Tirzepatide consumers have an easier time resisting food rewards in food-rich environments
